Globus Medical, Inc.
NYSE:GMED
69.75 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,568.476 | 1,022.843 | 958.102 | 789.042 | 785.368 | 712.969 | 635.977 | 563.994 | 544.753 | 474.371 | 434.459 | 385.994 | 331.478 | 288.195 | 254.344 |
| Cost of Revenue
| 548.174 | 263.725 | 239.223 | 217.463 | 179.975 | 159.41 | 150.453 | 134.705 | 132.803 | 110.857 | 100.343 | 75.199 | 68.796 | 53.825 | 41.607 |
| Gross Profit
| 1,020.302 | 759.118 | 718.879 | 571.579 | 605.393 | 553.559 | 485.524 | 429.289 | 411.95 | 363.514 | 334.116 | 310.795 | 262.682 | 234.37 | 212.737 |
| Gross Profit Ratio
| 0.651 | 0.742 | 0.75 | 0.724 | 0.771 | 0.776 | 0.763 | 0.761 | 0.756 | 0.766 | 0.769 | 0.805 | 0.792 | 0.813 | 0.836 |
| Reseach & Development Expenses
| 124.01 | 73.015 | 97.346 | 84.519 | 60.073 | 55.496 | 43.679 | 44.532 | 36.982 | 31.687 | 26.87 | 27.926 | 23.464 | 21.309 | 20.521 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 311.591 | 267.817 | 222.156 | 214.014 | 187.798 | 182.518 | 168.862 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 643.41 | 432.117 | 408.149 | 354.757 | 354.757 | 311.591 | 267.817 | 222.156 | 214.014 | 187.798 | 182.518 | 168.862 | 140.386 | 122.589 | 108.422 |
| Other Expenses
| 767.42 | 17.735 | 18.526 | 16.831 | 13.809 | 19.28 | 8.088 | 3.138 | 0.583 | 0.28 | 0.328 | -0.14 | -0.413 | 0.054 | -0.127 |
| Operating Expenses
| 818.452 | 522.867 | 524.021 | 456.107 | 428.639 | 376.675 | 319.405 | 270.166 | 250.996 | 219.485 | 209.388 | 196.788 | 163.85 | 143.898 | 128.943 |
| Operating Income
| 133.142 | 227.951 | 171.953 | 111.433 | 171.989 | 169.325 | 161.84 | 154.141 | 172.222 | 138.362 | 101.673 | 114.793 | 97.362 | 87.685 | 81.905 |
| Operating Income Ratio
| 0.085 | 0.223 | 0.179 | 0.141 | 0.219 | 0.237 | 0.254 | 0.273 | 0.316 | 0.292 | 0.234 | 0.297 | 0.294 | 0.304 | 0.322 |
| Total Other Income Expenses Net
| 165.393 | 15.068 | 8.454 | 14.466 | 17.957 | 11.721 | 3.809 | -1.844 | 11.851 | -5.387 | -22.727 | 0.646 | -1.883 | -2.733 | -2.016 |
| Income Before Tax
| 165.393 | 243.019 | 180.407 | 125.899 | 189.946 | 188.605 | 169.928 | 157.279 | 172.805 | 138.642 | 102.001 | 114.653 | 96.949 | 87.739 | 81.778 |
| Income Before Tax Ratio
| 0.105 | 0.238 | 0.188 | 0.16 | 0.242 | 0.265 | 0.267 | 0.279 | 0.317 | 0.292 | 0.235 | 0.297 | 0.292 | 0.304 | 0.322 |
| Income Tax Expense
| 42.52 | 52.85 | 31.216 | 23.614 | 34.736 | 32.131 | 62.58 | 52.938 | 60.021 | 46.157 | 33.389 | 40.822 | 36.165 | 33.281 | 29.745 |
| Net Income
| 122.873 | 190.169 | 149.191 | 102.285 | 155.21 | 156.474 | 107.348 | 104.341 | 112.784 | 92.485 | 68.612 | 73.831 | 60.784 | 54.458 | 48.733 |
| Net Income Ratio
| 0.078 | 0.186 | 0.156 | 0.13 | 0.198 | 0.219 | 0.169 | 0.185 | 0.207 | 0.195 | 0.158 | 0.191 | 0.183 | 0.189 | 0.192 |
| EPS
| 1.09 | 1.89 | 1.48 | 1.04 | 1.57 | 1.6 | 1.12 | 1.09 | 1.19 | 0.98 | 0.74 | 0.82 | 0.84 | 0.75 | 0.55 |
| EPS Diluted
| 1.07 | 1.85 | 1.44 | 1.01 | 1.52 | 1.54 | 1.1 | 1.08 | 1.17 | 0.97 | 0.73 | 0.8 | 0.81 | 0.72 | 0.54 |
| EBITDA
| 401.032 | 313.823 | 289.053 | 182.664 | 229.964 | 226.073 | 212.465 | 202.876 | 173.77 | 171.45 | 167.18 | 131.329 | 117.251 | 108.455 | 99.185 |
| EBITDA Ratio
| 0.256 | 0.307 | 0.302 | 0.232 | 0.293 | 0.317 | 0.334 | 0.36 | 0.319 | 0.361 | 0.385 | 0.34 | 0.354 | 0.376 | 0.39 |